China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate
China National Accord Medicines Corp Ltd cash flow reinvestment rate. China National Accord Medicines Corp Ltd (000028) has a Cash Flow Reinvestment Rate of 0.05x as of June 2025, reinvesting CN¥95.44 Million (capex CN¥50.09 Million plus investments CN¥45.35 Million) from operating cash flow of CN¥1.83 Billion. See 000028 financial flexibility score to measure the company's free cash flow as a share of total liabilities.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Cash Flow Reinvestment Rate of China National Accord Medicines Corp Ltd (1998–2024)
Cash flow reinvestment rate of China National Accord Medicines Corp Ltd from 1998 to 2024. Historical reinvestment intensity for China National Accord Medicines Corp Ltd across 26 annual periods. Explore debt repayment capacity of China National Accord Medicines Corp Ltd to assess how comfortably operating cash covers total debt obligations.
China National Accord Medicines Corp Ltd Cash Flow Reinvestment Rate by Year (1998–2024)
China National Accord Medicines Corp Ltd cash flow reinvestment rate by year from 1998 to 2024. Year-by-year capital reinvestment analysis for China National Accord Medicines Corp Ltd. For the full cash flow conversion analysis, see 000028 operating cash flow.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.15x | CN¥476.87 Million | CN¥3.27 Billion | CN¥282.70 Million | ▼ -6.4% |
| 2023 | 0.16x | CN¥457.64 Million | CN¥2.94 Billion | CN¥322.21 Million | ▼ -40.0% |
| 2022 | 0.26x | CN¥665.01 Million | CN¥2.56 Billion | CN¥322.19 Million | ▼ -16.4% |
| 2021 | 0.31x | CN¥514.46 Million | CN¥1.66 Billion | CN¥370.43 Million | ▲ +43.8% |
| 2020 | 0.22x | CN¥324.92 Million | CN¥1.50 Billion | CN¥293.83 Million | ▲ +43.6% |
| 2019 | 0.15x | CN¥301.17 Million | CN¥2.00 Billion | CN¥245.17 Million | ▼ -47.6% |
| 2018 | 0.29x | CN¥380.06 Million | CN¥1.32 Billion | CN¥255.48 Million | ▲ +70.1% |
| 2017 | 0.17x | CN¥217.09 Million | CN¥1.29 Billion | CN¥204.35 Million | ▼ -9.6% |
| 2016 | 0.19x | CN¥275.02 Million | CN¥1.47 Billion | CN¥265.89 Million | ▼ -13.7% |
| 2015 | 0.22x | CN¥226.73 Million | CN¥1.05 Billion | CN¥190.36 Million | ▼ -33.1% |
| 2013 | 0.32x | CN¥150.50 Million | CN¥465.03 Million | CN¥150.50 Million | ▼ -45.8% |
| 2012 | 0.60x | CN¥193.57 Million | CN¥323.96 Million | CN¥193.57 Million | ▼ -31.7% |
| 2011 | 0.88x | CN¥198.97 Million | CN¥227.32 Million | CN¥198.97 Million | ▲ +110.6% |
| 2010 | 0.42x | CN¥177.99 Million | CN¥428.16 Million | CN¥177.99 Million | ▲ +9.4% |
| 2009 | 0.38x | CN¥102.94 Million | CN¥270.85 Million | CN¥102.94 Million | ▲ +10.3% |
| 2008 | 0.34x | CN¥84.98 Million | CN¥246.58 Million | CN¥84.98 Million | ▼ -57.7% |
| 2007 | 0.81x | CN¥71.41 Million | CN¥87.70 Million | CN¥71.41 Million | ▲ +25.2% |
| 2006 | 0.65x | CN¥118.22 Million | CN¥181.73 Million | CN¥118.22 Million | ▲ +90.5% |
| 2005 | 0.34x | CN¥50.62 Million | CN¥148.28 Million | CN¥50.62 Million | ▲ +213.6% |
| 2004 | 0.11x | CN¥14.18 Million | CN¥130.30 Million | CN¥14.18 Million | ▼ -82.1% |
| 2003 | 0.61x | CN¥49.36 Million | CN¥81.22 Million | CN¥49.36 Million | ▼ -35.0% |
| 2002 | 0.94x | CN¥26.90 Million | CN¥28.76 Million | CN¥26.90 Million | ▲ +85.3% |
| 2001 | 0.50x | CN¥35.91 Million | CN¥71.16 Million | CN¥35.91 Million | ▼ -79.5% |
| 2000 | 2.47x | CN¥21.01 Million | CN¥8.52 Million | CN¥21.01 Million | ▲ +104.6% |
| 1999 | 1.21x | CN¥27.54 Million | CN¥22.84 Million | CN¥27.54 Million | ▼ -39.5% |
| 1998 | 1.99x | CN¥10.38 Million | CN¥5.21 Million | CN¥10.38 Million | — |